Effective Treatments for Thoracic Aortic Aneurysms (ETTAA Study): A Prospective Cohort Study
ETTAA
2 other identifiers
observational
2,200
1 country
1
Brief Summary
This is a prospective observational cohort study that will collect data from the point of referral through to secondary care, aiming for 3 years median follow-up (range 1-5 years). The data collected will allow estimation of the success of any intervention (in terms of reducing rate of aneurysm growth, rupture or dissection) as well as estimation of the risks associated with the three procedures. Clinical outcomes in the three treatment groups will be described. Aims We aim to answer the following questions:
- 1.Without procedural intervention for chronic thoracic aortic aneurysm (CTAA), what is the risk of aneurysm growth, dissection, rupture, permanent neurological injury or death? What is the effect on quality of life (QoL)?
- 2.If a patient has endovascular stent grafting (ESG) or open surgical repair (OSR), what is the risk of growth, dissection, rupture, permanent neurological injury or death?
- 3.How does QoL change from pre- to post intervention?
- 4.Can aneurysm or patient related predictors of good/poor treatment outcomes be determined?
- 5.What is the most cost-effective strategy in:
- 6.Patients eligible for either ESG or OSR?
- 7.Patients eligible for either ESG or best medical therapy (BMT)?
- 8.Patients eligible for either watchful waiting (WW) or intervention (ESG/ OSR)?
- 9.What further research is required? What would be the most important research to pursue?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2013
CompletedFirst Posted
Study publicly available on registry
December 13, 2013
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedMay 6, 2016
May 1, 2016
4.9 years
November 22, 2013
May 5, 2016
Conditions
Outcome Measures
Primary Outcomes (6)
Aneurysm Growth
1, 2, 3 , 4 and 5 years post recruitment
Quality of life
1, 2, 3 , 4 and 5 years post recruitment
Freedom from reintervention
1, 2, 3 , 4 and 5 years post recruitment
Freedom from death or permanent neurological injury
1, 2, 3 , 4 and 5 years post recruitment
Costs to the NHS
1, 2, 3 , 4 and 5 years post recruitment
Incremental cost per quality adjusted life year gained
1, 2, 3 , 4 and 5 years post recruitment
Study Arms (4)
Watchful Waiting
Patients with aneurysms considered to be at low risk of rupture will remain under surveillance with annual CT / MRI scans and multi-disciplinary team review (as per local practice). These patients' data will contribute to the natural history component of the study.
Best Medical Therapy
This refers to lifestyle modification (smoking cessation and dietary management) as well as medical management of hypercholesterolaemia and hypertension for patients who are considered unsuitable for, or who refuse, OSR / ESG.
Open Surgery (OSR)
Replacement of the aneurysmal aorta with prosthetic conduit via a sternotomy or thoracotomy with circulatory support.
Stenting (ESR)
Endovascular repair of the aneurysm via transluminal introduction of a stent-graft under X-ray guidance. Hybrid procedures that comprise a combination of a conventional surgical component and a transluminal repair are to be included in this group.
Interventions
Eligibility Criteria
Patients being referred to a specialist centre for diagnosis and treatment of their aneurysm
You may qualify if:
- Thoracic Aortic Aneurysm \> 4cm
- Age ≥18 years
- Able to give informed consent
You may not qualify if:
- Intervention required below the level of the coeliac axis
- Acute dissection or malperfusion syndromes (such as myocardial infarction,acute stroke or limb ischaemia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Papworth Hospital
Cambridge, Cambs, CB23 3RE, United Kingdom
Related Publications (1)
Sharples L, Sastry P, Freeman C, Gray J, McCarthy A, Chiu YD, Bicknell C, McMeekin P, Vallabhaneni SR, Cook A, Vale L, Large S. Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study. Health Technol Assess. 2022 Jan;26(6):1-166. doi: 10.3310/ABUT7744.
PMID: 35094747DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stephen Large, FRCS
Papworth Hospital NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2013
First Posted
December 13, 2013
Study Start
February 1, 2014
Primary Completion
January 1, 2019
Study Completion
July 1, 2019
Last Updated
May 6, 2016
Record last verified: 2016-05